Global Epirubicin Hydrochloride Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Epirubicin Hydrochloride market size will reach 249.58 Million USD in 2025 and is projected to reach 212.37 Million USD by 2032, with a CAGR of -2.28% (2025-2032). Notably, the China Epirubicin Hydrochloride market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Epirubicin hydrochloride is a chemotherapy medication used in the treatment of various cancers, including breast cancer, ovarian cancer, and certain types of leukemia. It belongs to a class of drugs known as anthracyclines and works by interfering with the growth and division of cancer cells. Epirubicin is typically administered intravenously, and its hydrochloride form enhances its solubility and stability in solution. While effective in treating cancer, epirubicin can have side effects, including nausea, vomiting, hair loss, and potential damage to the heart, so its use is carefully monitored by healthcare professionals to balance its therapeutic benefits with potential risks.
The major global manufacturers of Epirubicin Hydrochloride include Sterling Biotech, Zhejiang Hisun Pharma, Flavine, Teva API, Microbiopharm Japan, DZD Heze Pharma, Synbias Pharma, Intas Pharma, Humble Healthcaare, Lunan Pharmaceutical Group, Beijing Union Pharmaceutical Factory, Pfizer, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Epirubicin Hydrochloride. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Epirubicin Hydrochloride market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Epirubicin Hydrochloride market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Epirubicin Hydrochloride industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Epirubicin Hydrochloride Include:
Sterling Biotech
Zhejiang Hisun Pharma
Flavine
Teva API
Microbiopharm Japan
DZD Heze Pharma
Synbias Pharma
Intas Pharma
Humble Healthcaare
Lunan Pharmaceutical Group
Beijing Union Pharmaceutical Factory
Pfizer
Epirubicin Hydrochloride Product Segment Include:
10mg/5ml
50mg/25ml
Others
Epirubicin Hydrochloride Product Application Include:
Cancer
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Epirubicin Hydrochloride Industry PESTEL Analysis
Chapter 3: Global Epirubicin Hydrochloride Industry Porter's Five Forces Analysis
Chapter 4: Global Epirubicin Hydrochloride Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Epirubicin Hydrochloride Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Epirubicin Hydrochloride Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Epirubicin Hydrochloride Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Epirubicin Hydrochloride market size will reach 249.58 Million USD in 2025 and is projected to reach 212.37 Million USD by 2032, with a CAGR of -2.28% (2025-2032). Notably, the China Epirubicin Hydrochloride market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Epirubicin hydrochloride is a chemotherapy medication used in the treatment of various cancers, including breast cancer, ovarian cancer, and certain types of leukemia. It belongs to a class of drugs known as anthracyclines and works by interfering with the growth and division of cancer cells. Epirubicin is typically administered intravenously, and its hydrochloride form enhances its solubility and stability in solution. While effective in treating cancer, epirubicin can have side effects, including nausea, vomiting, hair loss, and potential damage to the heart, so its use is carefully monitored by healthcare professionals to balance its therapeutic benefits with potential risks.
The major global manufacturers of Epirubicin Hydrochloride include Sterling Biotech, Zhejiang Hisun Pharma, Flavine, Teva API, Microbiopharm Japan, DZD Heze Pharma, Synbias Pharma, Intas Pharma, Humble Healthcaare, Lunan Pharmaceutical Group, Beijing Union Pharmaceutical Factory, Pfizer, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Epirubicin Hydrochloride. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Epirubicin Hydrochloride market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Epirubicin Hydrochloride market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Epirubicin Hydrochloride industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Epirubicin Hydrochloride Include:
Sterling Biotech
Zhejiang Hisun Pharma
Flavine
Teva API
Microbiopharm Japan
DZD Heze Pharma
Synbias Pharma
Intas Pharma
Humble Healthcaare
Lunan Pharmaceutical Group
Beijing Union Pharmaceutical Factory
Pfizer
Epirubicin Hydrochloride Product Segment Include:
10mg/5ml
50mg/25ml
Others
Epirubicin Hydrochloride Product Application Include:
Cancer
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Epirubicin Hydrochloride Industry PESTEL Analysis
Chapter 3: Global Epirubicin Hydrochloride Industry Porter's Five Forces Analysis
Chapter 4: Global Epirubicin Hydrochloride Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Epirubicin Hydrochloride Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Epirubicin Hydrochloride Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Epirubicin Hydrochloride Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Epirubicin Hydrochloride Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Epirubicin Hydrochloride Product by Type
- 1.2.1 10mg/5ml
- 1.2.2 50mg/25ml
- 1.2.3 Others
- 1.3 Epirubicin Hydrochloride Product by Application
- 1.3.1 Cancer
- 1.3.2 Others
- 1.4 Global Epirubicin Hydrochloride Market Revenue and Sales Analysis
- 1.4.1 Global Epirubicin Hydrochloride Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Epirubicin Hydrochloride Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Epirubicin Hydrochloride Market Sales Price Trend Analysis (2020-2032)
- 1.5 Epirubicin Hydrochloride Market Development Status and Trends
- 1.5.1 Epirubicin Hydrochloride Industry Development Status Analysis
- 1.5.2 Epirubicin Hydrochloride Industry Development Trends Analysis
- 2 Epirubicin Hydrochloride Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Epirubicin Hydrochloride Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Epirubicin Hydrochloride Market Analysis by Country
- 4.1 Global Epirubicin Hydrochloride Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Epirubicin Hydrochloride Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Epirubicin Hydrochloride Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Epirubicin Hydrochloride Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Epirubicin Hydrochloride Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Epirubicin Hydrochloride Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Epirubicin Hydrochloride Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Epirubicin Hydrochloride Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Epirubicin Hydrochloride Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Epirubicin Hydrochloride Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Epirubicin Hydrochloride Average Sales Price by Manufacturers (2021-2025)
- 5.2 Epirubicin Hydrochloride Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Epirubicin Hydrochloride Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Epirubicin Hydrochloride Market Analysis by Type
- 6.1 Global Epirubicin Hydrochloride Market Revenue Analysis by Type
- 6.1.1 Global Epirubicin Hydrochloride Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Epirubicin Hydrochloride Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Epirubicin Hydrochloride Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Epirubicin Hydrochloride Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Sterling Biotech
- 7.1.1 Sterling Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Sterling Biotech Epirubicin Hydrochloride Product Portfolio
- 7.1.3 Sterling Biotech Epirubicin Hydrochloride Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Zhejiang Hisun Pharma
- 7.2.1 Zhejiang Hisun Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Zhejiang Hisun Pharma Epirubicin Hydrochloride Product Portfolio
- 7.2.3 Zhejiang Hisun Pharma Epirubicin Hydrochloride Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Flavine
- 7.3.1 Flavine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Flavine Epirubicin Hydrochloride Product Portfolio
- 7.3.3 Flavine Epirubicin Hydrochloride Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Teva API
- 7.4.1 Teva API Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Teva API Epirubicin Hydrochloride Product Portfolio
- 7.4.3 Teva API Epirubicin Hydrochloride Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Microbiopharm Japan
- 7.5.1 Microbiopharm Japan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Microbiopharm Japan Epirubicin Hydrochloride Product Portfolio
- 7.5.3 Microbiopharm Japan Epirubicin Hydrochloride Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 DZD Heze Pharma
- 7.6.1 DZD Heze Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 DZD Heze Pharma Epirubicin Hydrochloride Product Portfolio
- 7.6.3 DZD Heze Pharma Epirubicin Hydrochloride Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Synbias Pharma
- 7.7.1 Synbias Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Synbias Pharma Epirubicin Hydrochloride Product Portfolio
- 7.7.3 Synbias Pharma Epirubicin Hydrochloride Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Intas Pharma
- 7.8.1 Intas Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Intas Pharma Epirubicin Hydrochloride Product Portfolio
- 7.8.3 Intas Pharma Epirubicin Hydrochloride Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Humble Healthcaare
- 7.9.1 Humble Healthcaare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Humble Healthcaare Epirubicin Hydrochloride Product Portfolio
- 7.9.3 Humble Healthcaare Epirubicin Hydrochloride Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Lunan Pharmaceutical Group
- 7.10.1 Lunan Pharmaceutical Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Lunan Pharmaceutical Group Epirubicin Hydrochloride Product Portfolio
- 7.10.3 Lunan Pharmaceutical Group Epirubicin Hydrochloride Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 Beijing Union Pharmaceutical Factory
- 7.11.1 Beijing Union Pharmaceutical Factory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Product Portfolio
- 7.11.3 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.12 Pfizer
- 7.12.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Pfizer Epirubicin Hydrochloride Product Portfolio
- 7.12.3 Pfizer Epirubicin Hydrochloride Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Epirubicin Hydrochloride Industry Chain Analysis
- 8.2 Epirubicin Hydrochloride Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Epirubicin Hydrochloride Product Downstream Application Analysis
- 8.3.1 Global Epirubicin Hydrochloride Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Epirubicin Hydrochloride Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Epirubicin Hydrochloride Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Epirubicin Hydrochloride Typical Downstream Customers
- 8.5 Epirubicin Hydrochloride Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
